Vascular Flashcards
(141 cards)
Lymphocytic thrombophilic arteritis
Can mimic PAN - livedo racemosa and macular hyperpigmentation
Lymphocytic on histology
More mild
Have as a differential
Adenosine deaminase 2 deficiency
Found in children with cutaneous PAN
Gene is CECR1
Leads to strokes and immunodeficiency
Prediliction for medium vessel vasculitis
Infantile haemangioma epidemiology and risk factors
- most common first year of life
- 4-5% of infants experience
- F>M (2-5:1)
- risk factors: LBW, premature, placental insufficiency, advanced maternal age, Caucasian, family history, twins
Infantile haemangioma pathogenesis
- proliferating endothelial cells
- Signalling + pathways:
- GLUT1 (glucose transporter protein 1) expressed in IHs and the placenta
- Vascular endothelial growth factor (VEGF) changes
- Genetics:
- Somatic mutations in genes that encode proteins involved in VEGF signaling
- Familial haemangiomas linked to Chromosome 5q
- Hypoxia
- Demonstrated by association with hypoxic states - placenta praevia, etc
- hypoxia increases GLUT1 and VEGF –> mobilising vascular engothelial cells
- Hypoxia + oestrogen results in synergistic effect on haemangiomas endothelial cell proliferation
- Other things
- Other cells may influence - monocytes, fibroblasts, pericytes, mesenchymal cells, adipocytes, etc
Types of infantile haemangioma
- Superficial:superficial dermis, bright red –> most common ~50-60%
- Deep:deep dermis/subcutis, take longer to see, warm, ill-defined blue-purple masses with minimal or no overlying skin changes. When super deep mat gave arterial blood supply –> seen with USS –> least common ~15%
- Mixed:superficial and deep components, subsequently have both presentations
Patterns of infantile haemangioma involvement
- Focal: arises from simple localised nidus
- Segmental:covering a broad area or developmental unit in a plaque like manner
- often begin as broad patches of confluent or reticulated erythema and/or telangiectasia
- more likely to be associated with regional extra-cutaneous manifestations: PHACES and LUMBAR
- 4 segments to face:
- S1 fronto-temporal
- S2 maxillary
- S3 mandibular
- S4 fronto-nasal
- Indeterminate: difficult to classify
Subset: infantile haemangioma with minimal or arrested growth- display little or no growth beyond patches of reticulated erythema. these are more on the lower body and may develop recalcitrant ulceration or be associated with syndromes.
Phases of infantile haemangioma
‘Precursor lesion’: telangiectasias surrounded by vasoconstricted halo
- Early proliferation:rapid increase in size
- Mark out their territory early on
- as they proliferate become warmer and firmer in texture
- deep haemangiomas proliferate for a longer time
- 80% reach final size by end of this phase - mean age of 3 months
- Later proliferation:continued growth at a slower rate
- Plateau
- Involution
- Can occur as early as the first year of life
- 30% by 3 years, 70% by 7 years, 90% by 9 years
- when they involute, often no scar, occasionally atrophic, fibrofatty or telangiectatic residua
Infantile haemangioma complications
- Ulceration
- ~10% of cases
- more likely in lip and ano-genital region
- more likely in large, mixed or segmental
- median age 4 months
- painful, incr risk of infection, rarely bleeding
- Disfigurement
- Interference with function
- Syndromes
- Rarely can result in congestive heart failure
- Classified by location:
- Peri-ocular:
- compresses the globe –> astigmatism
- obstructs visual axis –> visual abnormalities
- Orbital
- Proptosis
- Nasal tip
- Deformity: cryano-nose
- Columella
- Ulcerate and cause deformities with underlying cartilage
- Lip
- Ulceration –> feeding difficulties
- Distortion of vermillion border –> significant cosmetic residua
- Pinna
- Ulceration –> scarring –> conductive hearing loss
- Breast
- Breast asymmetry
- Peri-ocular:
PHACES
- Posterior fossa
- Haemangioma
- Arterial anomalies of cardiac and cerebral vessels
- Cardiac defects
- Eye anomolies
- Sternal defects
LUMBAR
- Lower body/lumbo-sacral haemangioma
- Urogenital abnormaltiies
- Myelopathy
- Bony deformities
- Anorectal and arterial anomalities
- Renal anomalies
PELVIS
- Perineal Haemangioma
- External genital malformations
- Lipomyelomeningocele
- Imperforate anus
- Skin tags
Infantile haemangiomas - locations with associations
large facial haemangiomas >5 cm often associated with syndrome
- Lower facial/beard:associated with airway involvement
- Midline lumbosacral:marker for occult spinal dysraphism
- Liver most common site of visercal haemangiomas in patients with multiple skin lesions
- can be focal, multi-focal or diffuse
- when diffuse, associated with hypothyroidism, high output cardiac failure due to AV and arterioportal shunts, abdominal compartment syndrome
- Screen these with serial ultrasounds, clinical assessments and laboratory evaluation for hypothyroidism
- When to look for extra-cutaneous:
- > 5 skin lesions
- Large segmental
Thyroid changes with infantile haemangioma
- haemangiomas secrete type 3 iodothyronine deiodinase - this enzyme deactivates thyroid hormone, subsequently leading to hypothyroidism
- screen for this in hepatic haemangiomas or large cutaneous
IH histology
- proliferating plump endothelial cells and pericytes
- small vascular lumens focally
- later in proliferation: lobules of endothelial massess separated by fibrous septae, larger feeding and draining vessels, some mitotic figures
- Involution: flattening of endothelium and reduced mitotic figures, fibrous and fatty tissue separating the vessels within and between lobules. fully involuted: fibrofatty tissues
- Special stains
- GLUT-1 positive
DDx for IH
- Superficial
- pyogenic granulomas
- tufted angioma
- spindle cell haemangioma
- verrucous venous malformation
- Deep
- venous, lymphatic or combined malformation
- congential haemangioma
- kaposiform haemangiodenothelioma
- Kasabach-Merritt phenomenon - life threatening, thrombocytopaenic coagulopathy
- Congenital fibrosarcoma
IH Management
- Active non-intervention
- close observation
- education
- discuss re bleeding and ulceration
- Ulceration
- Local wound care
- Infection treatment
- metronidazole gel in areas concerned of gram neg
- hydrocolloid dressings and foam dressings - i.e. Mepilex
- compression dressings for limbs
- Pain relief
- occlusive dressings
- oral panadol
- topical lidocaine ointment
- Beta-blockers
- Pulsed dye laser
- Systemic treatment
- indications:
- threatened vital functions - vision, airway
- potential for disfigurement - nose, columella, lip
- severe/recalcitrant
- high output cardiac failure
- indications:
Topical beta blocker
- Timolol - non-selective beta-blocker for small lesions <1 mm thick and 2.5 cm in size
- 0.5 % gel or ointment, drop BD to area
- Dose be limited to <0.25 mg/kg/day
Intralesional steroids for IH
- IL used for areas such as the lip
- Triamcimolone not be more than 3-5 mg/kg
Propranolol in IH
- MOA: vasoconstriction via beta-2 adrenergic receptors on endothelial cells, disruption of VEGF signalling that drives vasculogenesis
- Target 2-3 mg/kg/day
- Continue for 6-12 months then tapered slowly to prevent rebound tachycardia
- ~25% then have recurrence after cessation
- A/E:
- hypotension, bradycardia
- hypoglycaemia –> give with food
- bronchospasm –> history of airway reactivity is an absolute contraindicatiojn
- More common:
- sleep disturbance
- cold extremities
- diarrhoea
- somnolence
- Atenolol may also work as well
Laser for IH
- PDL
- 585-600 nm wavelength
- most beneficial for superficial
- generally well tolerated
- a/e: pigment alteration, ulceration, atrophic scarring
- Nd:YAG
- might be better for deeper lesions
Vascular malformation definition
Localised defects of vascular morphogenesis - likely causes by dysfunction in pathways regulating the foramtion of vascular channels during embryonic development. Not truly proliferation.
Haemangiomatosis
5 or more haemangiomas
Liver haemangioma acts as AVM and can have cardiac failure
Consumptive hypothyroidism
CM-AVM SYNDROME
Autosomal dominant
Capillary malformations + AVM
Fast flow vascular anomalies
Skin mm bone brain and spine
Cx: heart failure, bleeding, neurological sequelae
Gene: RASA1 and EPHB4
Evidence to suggest that CMs and AVMs due to second hit phenomenon
KS aetiology
- HHV-8: promotes cellular proliferation, angiogenesis and prevent apoptosis
- This is present in all Kaposi Sarcoma, though only a small percentage of those with HHV-8 get Kaposi sarcoma
- Argue as to whether is hyperplasia or neoplasia